![]()
|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Papers In Press, published online ahead of print June 14, 2006
Dev. Mol. Biol., Albert Einstein College of Medicine, Bronx, NY 10461
Corresponding Author: lizhu{at}aecom.yu.edu
Skp2 is well known as the F-box protein of the SCFSkp2Roc1 complex targeting p27 for ubiquitylation. Skp2 also forms complexes with cyclin A, which are particularly abundant in cancer cells due to frequent Skp2 overexpression, but the mechanism and significance of this interaction remain unknown. Here, we report that Skp2-cyclin A interaction is mediated by novel interaction sequences on both Skp2 and cyclin A, distinguishing it from the well-known RxL-HP interaction between cyclins and cyclin-binding proteins. Furthermore, a short peptide derived from the mapped cyclin A binding sequences of Skp2 can block Skp2-cyclin A interaction but not p27-cyclin A interaction, whereas a previously identified RxL peptide can block p27-cyclin A interaction but not Skp2-cyclin A interaction. Functionally, Skp2-cyclin A interaction is separable from Skp2s ability to mediate p27 ubiquitylation. Rather, Skp2-cyclin A interaction serves to directly protect cyclin A/Cdk2 from inhibition by p27 through competitive binding. Finally, we show that disruption of cyclin A binding with point mutations in the cyclin A binding domain of Skp2 compromises the ability of overexpressed Skp2 to counter cell cycle arrest by a p53/p21 mediated cell cycle checkpoint without affecting its ability to cause degradation of cellular p27 and p21. These findings reveal a new functional mechanism of Skp2 and a new regulatory mechanism of cyclin A.
J. Biol. Chem, 10.1074/jbc.M603105200
Submitted on March 31, 2006
Revised on June 14, 2006
Accepted on June 14, 2006
SKP2 contains a novel cyclin a binding domain that directly protects cyclin A from inhibition by p27Kip1
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
W.-J. Song, W. E. Schreiber, E. Zhong, F.-F. Liu, B. D. Kornfeld, F. E. Wondisford, and M. A. Hussain Exendin-4 Stimulation of Cyclin A2 in {beta}-Cell Proliferation Diabetes, September 1, 2008; 57(9): 2371 - 2381. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Wang, D. Sun, P. Ji, J. Mohler, and L. Zhu An AR-Skp2 pathway for proliferation of androgen-dependent prostate-cancer cells J. Cell Sci., August 1, 2008; 121(15): 2578 - 2587. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Ji, D. Sun, H. Wang, F. Bauzon, and L. Zhu Disrupting Skp2-cyclin A interaction with a blocking peptide induces selective cancer cell killing Mol. Cancer Ther., February 1, 2007; 6(2): 684 - 691. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |